CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation (NYSE:CVS)

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites,, and, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Retailers - NEC
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web:
  • Market Cap: $78.86492 billion
  • Outstanding Shares: 1,018,795,000
Average Prices:
  • 50 Day Moving Avg: $78.72
  • 200 Day Moving Avg: $79.38
  • 52 Week Range: $69.30 - $98.66
  • Trailing P/E Ratio: 16.71
  • Foreward P/E Ratio: 12.58
  • P/E Growth: 1.67
Sales & Book Value:
  • Annual Revenue: $178.83 billion
  • Price / Sales: 0.46
  • Book Value: $32.95 per share
  • Price / Book: 2.43
  • Annual Dividend: $2.00
  • Dividend Yield: 2.6%
  • EBIDTA: $12.81 billion
  • Net Margins: 2.86%
  • Return on Equity: 17.56%
  • Return on Assets: 6.64%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 1.08%
  • Quick Ratio: 0.56%
  • Average Volume: 6.26 million shs.
  • Beta: 0.92
  • Short Ratio: 3.9

Frequently Asked Questions for CVS Health Corporation (NYSE:CVS)

What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation declared a quarterly dividend on Thursday, March 2nd. Investors of record on Friday, April 21st will be given a dividend of $0.50 per share on Monday, May 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Wednesday, April 19th. View CVS Health Corporation's Dividend History.

How were CVS Health Corporation's earnings last quarter?

CVS Health Corporation (NYSE:CVS) announced its quarterly earnings data on Tuesday, May, 2nd. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.07. The firm earned $44.51 billion during the quarter, compared to analysts' expectations of $44.20 billion. CVS Health Corporation had a net margin of 2.86% and a return on equity of 17.56%. The business's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.18 EPS. View CVS Health Corporation's Earnings History.

When will CVS Health Corporation make its next earnings announcement?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, August, 8th 2017. View Earnings Estimates for CVS Health Corporation.

What guidance has CVS Health Corporation issued on next quarter's earnings?

CVS Health Corporation updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of $5.77-5.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.86. CVS Health Corporation also updated its Q2 guidance to $1.29-1.33 EPS.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

18 brokerages have issued 1-year price objectives for CVS Health Corporation's stock. Their forecasts range from $77.00 to $120.00. On average, they anticipate CVS Health Corporation's stock price to reach $94.27 in the next twelve months. View Analyst Ratings for CVS Health Corporation.

What are analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)
  • 3. According to Zacks Investment Research, "CVS Health posted better-than-expected second-quarter with respected to adjusted EPS. However, revenues missed the Zacks Consensus Estimate. The company’s Pharmacy Services segment continues to benefit from growth in the Specialty Pharmacy business while the Retail Pharmacy segment is gaining from increased same-store sales. We take note of the recently completed Omnicare and Target Pharmacy buyouts which, according to CVS, are strategically perfect fits. CVS Health expects to benefit with multiple opportunities for driving enterprise value from Omnicare and Target in both the near and long term. CVS Health also expects to see market share gain in its specialty pharmacy suite of services with differentiated specialty offerings providing a high level of clinical support to patients. However, the competitive landscape remains tough. The tussle for market share gain in the PBM and retail space also warrants caution." (8/3/2016)

Who are some of CVS Health Corporation's key competitors?

Who are CVS Health Corporation's key executives?

CVS Health Corporation's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board
  • Larry J. Merlo, President, Chief Executive Officer, Director
  • David M. Denton, Chief Financial Officer, Executive Vice President
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President
  • Stephen J. Gold, Executive Vice President, Chief Information Officer
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy
  • J. David Joyner, Executive Vice President

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.12%), BlackRock Inc. (6.00%), State Street Corp (4.32%), FMR LLC (2.33%), Bank of America Corp DE (2.20%) and Massachusetts Financial Services Co. MA (1.86%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Stephen J Gold and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corporation.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including C WorldWide Group Holding A S, FMR LLC, Wellington Management Group LLP, Janus Capital Management LLC, Ameriprise Financial Inc., Massachusetts Financial Services Co. MA, Caisse DE Depot ET Placement DU Quebec and Alliancebernstein L.P.. Company insiders that have sold CVS Health Corporation stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corporation.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., LSV Asset Management, Vanguard Group Inc., Schroder Investment Management Group, St. James Investment Company LLC, Morgan Stanley, Swiss National Bank and Edgar Lomax Co. VA. View Insider Buying and Selling for CVS Health Corporation.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health Corporation's stock price today?

One share of CVS Health Corporation stock can currently be purchased for approximately $80.12.

MarketBeat Community Rating for CVS Health Corporation (NYSE CVS)
Community Ranking:  3.7 out of 5 (  )
Outperform Votes:  777 (Vote Outperform)
Underperform Votes:  277 (Vote Underperform)
Total Votes:  1,054
MarketBeat's community ratings are surveys of what our community members think about CVS Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 6 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $94.27 (17.67% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/13/2017Cowen and CompanyReiterated RatingOutperform$86.00LowView Rating Details
6/9/2017Jefferies Group LLCReiterated RatingHold$82.00LowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
3/28/2017GuggenheimReiterated RatingBuy$90.00LowView Rating Details
3/18/2017Leerink SwannSet Price TargetBuy$90.00LowView Rating Details
2/28/2017Bank of America CorporationReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
2/2/2017Robert W. BairdDowngradeOutperform -> Neutral$86.00 -> $77.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
12/18/2016Oppenheimer Holdings, Inc.Set Price TargetBuy$88.00N/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/8/2016Citigroup Inc.Lower Price TargetNeutral$115.00 -> $108.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00N/AView Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00N/AView Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00N/AView Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00N/AView Rating Details
11/2/2015J P Morgan Chase & CoLower Price TargetOverweight$128.00 -> $123.00N/AView Rating Details
(Data available from 6/27/2015 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
Earnings by Quarter for CVS Health Corporation (NYSE:CVS)
Earnings History by Quarter for CVS Health Corporation (NYSE CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
2017 EPS Consensus Estimate: $5.87
2018 EPS Consensus Estimate: $6.52
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20174$1.51$1.64$1.60
Q4 20174$1.71$1.90$1.78
Q1 20183$1.25$1.49$1.35
Q2 20183$1.43$1.62$1.50
Q3 20182$1.73$1.76$1.75
Q4 20182$1.90$1.95$1.93
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Most Recent Dividend:5/1/2017
Annual Dividend:$2.00
Dividend Yield:2.50%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:41.67% (Trailing 12 Months of Earnings)
34.07% (Based on This Year's Estimates)
31.40% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History by Quarter for CVS Health Corporation (NYSE CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 81.98%
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CVS Health Corporation (NYSE:CVS)
Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logoHere's Why Diplomat Pharmacy Inc. Shares Are Down as Much as 13% - June 26 at 10:29 PM logoComparing Walgreens’s Stock Market Performance with Its Peers’ - June 26 at 5:27 PM logoWall Street Sees a 22% Upside in Walgreens - June 26 at 5:27 PM logoCVS Health Corporation Target of Unusually Large Options Trading (CVS) - June 26 at 1:28 PM logoWhy CVS Health Corp (CVS) Stock Will Win BIG With Trumpcare - - June 23 at 10:12 PM logoDiscussing Walgreens’s Top Line ahead of Its Fiscal 3Q17 Results - June 23 at 5:11 PM logoWhere Will Walgreens’ Earnings Head in Fiscal 3Q17? - June 23 at 5:11 PM logoHere’s who could lead Uber out of its scandals - June 22 at 5:00 PM logoPoints of Light Recognizes CVS Health As One Of The 50 Most Community-Minded Companies In The United States - June 22 at 5:00 PM logo Brokerages Expect CVS Health Corporation (CVS) Will Post Quarterly Sales of $45.36 Billion - June 22 at 10:30 AM logoHelena Foulkes Sells 20,332 Shares of CVS Health Corporation (CVS) Stock - June 21 at 7:24 PM logoCVS Health Set to Take a Turn for the Worse - June 20 at 5:19 PM logoEosinophilic Esophagitis: Major Market Opportunity for Dupixent? - June 20 at 5:19 PM logoCVS Health Corp. – Value Analysis (NYSE:CVS) : June 20, 2017 - June 20 at 5:19 PM logoZacks: Brokerages Expect CVS Health Corporation (CVS) to Post $1.31 Earnings Per Share - June 20 at 4:12 PM logoCVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : June 19, 2017 - June 19 at 7:00 PM logoCould Amazon Get Into the Pharmacy Game Next? - June 19 at 7:00 PM logoRite Aid Stock Just Had Its Best Gain In 20 Months As Walgreens Deadline Nears - June 19 at 7:00 PM logoCVS & Walgreens: Are Pharmacies in Amazon's Crosshairs? - June 19 at 1:57 PM logoAmazon destroys $28.5B of competitors' stock wealth after Whole Foods buy - June 18 at 4:27 PM logoCVS Health Corporation's (CVS) Outperform Rating Reaffirmed at Cowen and Company - June 18 at 4:20 PM logoWhy Whole Foods Market's Gain Is CVS Health's and Walgreens' Loss Today - Motley Fool - June 17 at 3:24 AM logoDividend Growth All-Stars: CVS Health - Seeking Alpha - June 17 at 3:24 AM logo3 Stocks With Better Dividends Than CVS Health Corporation - Motley Fool - June 17 at 3:24 AM logoDividend Growth All-Stars: CVS Health Corp. - June 16 at 5:22 PM logoWhy Whole Foods Market's Gain Is CVS Health's and Walgreens' Loss Today - June 16 at 5:22 PM logoTraders Purchase High Volume of Put Options on CVS Health Corporation (CVS) - June 16 at 12:04 PM logo3 Stocks With Better Dividends Than CVS Health Corporation - June 15 at 11:16 AM logoThe Long Case For CVS Health Corporation - June 14 at 10:34 PM logoInsider Selling: CVS Health Corporation (CVS) CFO Sells 230,510 Shares of Stock - June 13 at 7:28 PM logoETFs with exposure to CVS Health Corp. : June 12, 2017 - June 13 at 4:15 PM logoCVS Health Corporation (CVS) Given Average Recommendation of "Buy" by Brokerages - June 13 at 12:36 PM logoCVS Health Joins Drug Store News and Mack Elevation in Convening Health Innovation Summit - June 13 at 12:23 PM logoCVS Health Corporation (CVS) Cut to "Buy" at Vetr Inc. - June 12 at 9:40 PM logoCVS: Undervalued Cash Cow - Seeking Alpha - June 12 at 5:33 PM logoCVS: A Value Trap? - Seeking Alpha - June 12 at 5:33 PM logoCVS Health: Is The Amazon Threat Realistic? - Seeking Alpha - June 12 at 5:33 PM logoCVS Health Corp (CVS) Lifted to Strong-Buy at Vetr Inc. - June 11 at 7:06 PM logoJefferies Group LLC Reiterates Hold Rating for CVS Health Corp (CVS) - June 9 at 5:08 PM logoHow Caused CVS Health's Shares to Drop 6% in May - June 9 at 5:02 PM logoRite Aid share prices fall on report regarding Walgreens deal - June 9 at 5:02 PM logoFTC Expected To Block Rite Aid-Walgreens Deal: Report - June 9 at 5:02 PM logoCVS, two others face suit over EpiPen prices - June 7 at 4:57 PM logoCVS's Good-Health Mission Raises Burning Question: Should Shoppers Care? - June 7 at 4:57 PM logoCVS Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substances to Combat Opioid Epidemic, Reduce Robbery Incidents - June 7 at 4:57 PM logoCVS Health (CVS) Down 3.6% Since Earnings Report: Can It Rebound? - Nasdaq - June 6 at 4:50 PM logoCVS - A 50% Return By 2020? - Seeking Alpha - June 6 at 4:50 PM logoExpress Scripts, CVS face suit over EpiPen prices - June 6 at 4:49 PM logoTop Analyst Reports for ExxonMobil, JPMorgan, Intel and MasterCard - June 5 at 9:36 PM logoVetr Inc. Lowers CVS Health Corp (CVS) to Buy - June 5 at 6:16 PM



CVS Health Corporation (CVS) Chart for Tuesday, June, 27, 2017

This page was last updated on 6/27/2017 by Staff